Raheja Manohar K.
Known title: EVP, Research & DevelopmentCIK: 0002042497
Raheja Manohar K.'s purchase track record
How the stock did after each of Raheja Manohar K.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since November 19, 2024
Stock higher 6 months later
33%
3 months: 33%
Median 6-month return
-7.5%
3 months: -29.7%
Beat the S&P 500
33%
median -5.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/12/2025 | SGHT | $53K | +55.8% | +26.8% | +16.7% |
| 11/29/2024 | SGHT | $51K | -33.6% | -7.5% | -2.0% |
| 11/19/2024 | SGHT | $7K | -29.7% | -13.3% | +0.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SGHT | ▲ Buy | Grant | 12,767 | $39K | 5/16/2025 | View on chart |
| SGHT | ▲ Buy | Open Market | 10,000 | $26K | 3/13/2025 | View on chart |
| SGHT | ▲ Buy | Open Market | 10,000 | $27K | 3/12/2025 | View on chart |
| SGHT | ▲ Buy | Grant | 24,000 | $0 | 3/11/2025 | View on chart |
| SGHT | ▲ Buy | Open Market | 5,000 | $19K | 12/6/2024 | View on chart |
| SGHT | ▲ Buy | Open Market | 3,376 | $13K | 12/3/2024 | View on chart |
| SGHT | ▲ Buy | Open Market | 4,624 | $18K | 11/29/2024 | View on chart |
| SGHT | ▲ Buy | Open Market | 2,000 | $7K | 11/19/2024 | View on chart |
| SGHT | ▲ Buy | Grant | 96,000 | $441K | 11/12/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting
Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.
Sight Sciences to Show OMNI Ultra System at 2026 AOO Meeting. Sight Sciences plans to debut its new OMNI Ultra Surgical System at the upcoming American Academy of Ophthalmology Annual Meeting. This event highlights the company's continued focus on advancing ab interno canaloplasty technology. The stock is currently trading near its 52-week high, reflecting strong recent momentum.